{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T05:45:42Z","timestamp":1772948742038,"version":"3.50.1"},"reference-count":14,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermedades infecciosas y microbiologia clinica (English ed.)"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.eimce.2026.503060","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T12:35:20Z","timestamp":1771590920000},"page":"503060","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Delafloxacin's in vitro activity against bacteroides and its potential place in therapy"],"prefix":"10.1016","volume":"44","author":[{"given":"Maialen","family":"Larrea Ayo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iker Alonso","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regino","family":"Rodr\u00edguez \u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maider","family":"Zuriarrain Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Lejarraga Ca\u00f1as","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bego\u00f1a","family":"Vilar Achabal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimce.2026.503060_bib0005","article-title":"Time for some group therapy: update on identification, antimicrobial resistance, taxonomy, and clinical significance of the Bacteroides fragilis group","volume":"21","author":"Jean","year":"2022","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimce.2026.503060_bib0010","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1128\/AAC.00181-13","article-title":"A combined pharmacodynamic quantitative and qualitative model reveals the potent activity of daptomycin and delafloxacin against Staphylococcus aureus biofilms","volume":"57","author":"Bauer","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.eimce.2026.503060_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107241","article-title":"Antimicrobial resistance surveillance of Bacteroides fragilis isolated from blood cultures, Europe, 2022 (ReSuBacfrag)","volume":"64","author":"Buhl","year":"2024","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.eimce.2026.503060_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.anaerobe.2021.102447","article-title":"UK Bacteroides species surveillance survey: change in antimicrobial resistance over 16 years (2000\u20132016)","volume":"72","author":"Copsey-Mawer","year":"2021","journal-title":"Anaerobe"},{"issue":"17","key":"10.1016\/j.eimce.2026.503060_bib0025","doi-asserted-by":"crossref","first-page":"e37049","DOI":"10.1016\/j.heliyon.2024.e37049","article-title":"Multi-omics approach for understanding the response of Bacteroides fragilis to carbapenems","volume":"10","author":"Zholdybayeva","year":"2024","journal-title":"Heliyon"},{"issue":"3","key":"10.1016\/j.eimce.2026.503060_bib0030","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00430-023-00765-w","article-title":"Phenotypic and genotypic identification of carbapenem resistance in Bacteroides fragilis clinical strains","volume":"212","author":"Kierzkowska","year":"2023","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.eimce.2026.503060_bib0035","unstructured":"European Committee on antimicrobial susceptibility testing, Breakpoint Tables for Interpretation of MICs and Zone Diameters, 2024.http:\/\/eucast.org."},{"issue":"12","key":"10.1016\/j.eimce.2026.503060_bib0040","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s40265-020-01358-0","article-title":"Delafloxacin: a review in acute bacterial skin and skin structure infections","volume":"80","author":"Scott","year":"2020","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.eimce.2026.503060_bib0045","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s40121-018-0198-x","article-title":"Delafloxacin: a novel anionic fluoroquinolone with unique pharmacologic properties and activity against resistant pathogens","volume":"7","author":"Jorgensen","year":"2018","journal-title":"Infect Dis Ther"},{"issue":"2","key":"10.1016\/j.eimce.2026.503060_bib0050","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1128\/AAC.01201-10","article-title":"Antibacterial activity of delafloxacin against Staphylococcus aureus in vitro and in a murine model of skin infection","volume":"55","author":"Lemaire","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.eimce.2026.503060_bib0055","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/jac\/dkx543","article-title":"Pharmacokinetics and pharmacodynamics of delafloxacin against Staphylococcus aureus in a murine thigh infection model","volume":"73","author":"Mogle","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimce.2026.503060_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.anaerobe.2023.102816","article-title":"In vitro activity of delafloxacin against anaerobic bacteria compared with other antimicrobials","volume":"85","author":"Cobo","year":"2024","journal-title":"Anaerobe"},{"issue":"8","key":"10.1016\/j.eimce.2026.503060_bib0065","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3390\/antibiotics12081241","article-title":"Updated review on clinically-relevant properties of delafloxacin","volume":"12","author":"Turban","year":"2023","journal-title":"Antibiotics (Basel)"},{"issue":"3","key":"10.1016\/j.eimce.2026.503060_bib0070","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ijantimicag.2017.08.033","article-title":"Clinical relevance of metronidazole and peripheral neuropathy: a systematic review of the literature","volume":"51","author":"Goolsby","year":"2018","journal-title":"Int J Antimicrob Agents"}],"container-title":["Enfermedades infecciosas y microbiologia clinica (English ed.)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2529993X2600033X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2529993X2600033X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T16:24:49Z","timestamp":1772900689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2529993X2600033X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2529993X2600033X"],"URL":"https:\/\/doi.org\/10.1016\/j.eimce.2026.503060","relation":{},"ISSN":["2529-993X"],"issn-type":[{"value":"2529-993X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Delafloxacin's in vitro activity against bacteroides and its potential place in therapy","name":"articletitle","label":"Article Title"},{"value":"Enfermedades infecciosas y microbiologia clinica (English ed.)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eimce.2026.503060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.eimc.2025.503060","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"503060"}}